Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
35.74    1.02 (2.94%)
Bid:
35.68
Ask:
35.80
Spread: 0.12 (0.336%)
Market Cap: £571.49m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

CEO departure and succession plan

27 Feb 2026 07:01

RNS Number : 6093U
Hays PLC
27 February 2026
 

 

 

Hays plc

CEO departure and succession plan

 

27 February 2026

Hays plc ('Hays' or the 'Company') today announces that the Company's Chief Executive Officer (CEO), Dirk Hahn, is stepping down as CEO and as a Director with immediate effect for personal reasons.

Mark Dearnley, Chief Digital and Technology Officer, will become interim Chief Executive Officer until a permanent successor is in place.

Michael Findlay, as Non-Executive Chair, will work closely with Mark and the Hays Executive Leadership Team to ensure continuity and progress on the Group's strategic and commercial priorities.

A recruitment process to identify a permanent successor will begin immediately, led by the Nomination Committee with the support of external consultants.

Michael Findlay, Chair said:

"On behalf of the Board, I would like to thank Dirk for his significant contribution to Hays over the last 28 years. During his tenure, he demonstrated exceptional leadership, notably in building our German business and resetting Hays' strategy. On behalf of all Hays colleagues, I wish him every success in the future.

We are grateful to Mark for agreeing to step in as Interim CEO. Mark is an accomplished business leader and is well-placed to lead the Company as we continue to execute on our strategic and operational priorities"

Dirk Hahn, outgoing CEO, said:

"It has been a great honour to be part of Hays for the past 28 years and a privilege to lead the business in recent years. Thank you to the many remarkable colleagues I have worked with over the years. Hays is a great company with a bright and exciting future ahead of it"

There is no further information required to be disclosed in accordance with UK Listing Rule 6.4.8(R).

 

Notes:

1. In accordance with section 430(2B) Companies Act 2006, a statement concerning particulars of remuneration payments for Dirk Hahn will be published on the Company's website.

2. All remuneration arrangements will be consistent with the Remuneration Policy as approved by shareholders at the 2023 AGM. Full details will be disclosed in the Directors' Remuneration Report for FY26.

 

 

 

For further information please contact:

Hays plc

Rachel Ford

General Counsel & Company Secretary 

+44 (0) 333 010 2682 

Kean Marden

Head of Investor Relations & M&A

+44 (0) 333 010 7092

 

 

FGS Global

Guy Lamming

hays@fgsglobal.com

Anjali Unnikrishnan

Richard Crowley

 

 

 

 

LEI: 213800QC8AWD4BO8TH08

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAKABDFBKDQBB
Date   Source Headline
8th Jun 202611:10 amRNSShare Buyback Programme
8th Jun 202611:05 amRNSTransaction in Own Shares
4th Jun 20262:18 pmRNSDirector/PDMR Shareholding
1st Jun 202611:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSShare buyback programme
27th May 20269:14 amRNSHolding(s) in Company
19th May 20265:00 pmRNSDirector/PDMR Shareholding
18th May 20267:05 amRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSCEO Appointment
1st May 202610:00 amRNSTotal Voting Rights
29th Apr 20264:06 pmRNSDirector/PDMR Shareholding
28th Apr 20269:59 amRNSDirector/PDMR Shareholding
22nd Apr 20262:09 pmRNSHolding(s) in Company
22nd Apr 20262:06 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSThird Quarter Trading Statement
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 202611:00 amRNSTotal Voting Rights
27th Mar 20265:00 pmRNSHolding(s) in Company
27th Mar 20264:11 pmRNSDirector/PDMR Shareholding
25th Mar 202610:05 amRNSDirector/PDMR Shareholding
4th Mar 20261:24 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:08 pmRNSDirector/PDMR Shareholding
2nd Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:00 amRNSTotal Voting Rights
27th Feb 20264:15 pmRNSHolding(s) in Company
27th Feb 20267:01 amRNSCEO departure and succession plan
27th Feb 20267:00 amRNSHalf-Year Report
2nd Feb 202611:00 amRNSTotal Voting Rights
14th Jan 20267:00 amRNSSecond Quarter Trading Statement
5th Jan 20267:00 amRNSCEO update
2nd Jan 202610:00 amRNSTotal Voting Rights
1st Dec 202511:00 amRNSTotal Voting Rights
21st Nov 20253:10 pmRNSDirector/PDMR Shareholding
19th Nov 20252:33 pmRNSResult of AGM
11th Nov 202512:00 pmRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSCEO Medical Leave
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 202510:00 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 202511:00 amRNSShare buyback programme
10th Oct 20257:00 amRNSFirst Quarter Trading Statement
6th Oct 202512:00 pmRNSPublication of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.